Fast Market Research

"Global PVA Drugs Market 2014-2018" Is Now Available at Fast Market Research

New Pharmaceuticals research report from TechNavio is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 07/10/2014 -- Vaginal atrophy is defined as decrease in estrogen production. Less estrogen leads to thinning, drying, and decreased elasticity of the vaginal tissues. PVA is defined as the decrease in estrogen after the menopause. Up to 40 percent of postmenopausal women have symptoms of atrophic vaginitis. In PVA there are symptoms of redness, burning, itching, dryness, irritation, and dyspareunia. HRT, estrogen creams, and other topical preparations are used in the treatment of PVA.

TechNavio's analysts forecast the Global PVA Drugs market will grow at a CAGR of 7.1 percent over the period 2013-2018.

View Full Report Details and Table of Contents

Covered in this Report

The Global PVA Drugs market can be divided into two segments: Topical Estrogen and Systemic Estrogen. To calculate the market size, the report considers the revenue generated from the sales of various drugs (creams, tablets, and rings) used in the treatment of PVA.

TechNavio's report, the Global PVA Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global PVA Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas

Key Vendors

- Actavis plc
- Novo Nordisk A/S
- Pfizer Inc.
- Shionogi & Co. Ltd.

Other Prominent Vendors

- ANI Pharmaceuticals Inc.
- Bionovo Inc.
- EndoCeutics Inc.
- QuatRx Pharmaceutical Co.
- PeP-Tonic Medical AB
- Teva Pharmaceutical Industries Ltd.
- Therapeutics MD Inc.
- Upsher-Smith Laboratories Inc.

Market Driver

- Significant Unmet Need.
- For a full, detailed list, view our report.

Market Challenge

- Increasing Number of Patent Expirations.
- For a full, detailed list, view our report.

Market Trend

- Increase in Awareness of PVA.
- For a full, detailed list, view our report.

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Actavis plc, Novo Nordisk A/S, Pfizer Inc., Shionogi & Co. Ltd., ANI Pharmaceuticals Inc., Bionovo Inc., EndoCeutics Inc., QuatRx Pharmaceutical Co., PeP-Tonic Medical AB, Teva Pharmaceutical Industries Ltd., Therapeutics MD Inc., Upsher-Smith Laboratories Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Global Generic Drugs Market 2014-2018
- Global Pain Management Drugs Market 2014-2018
- Global CRAMS Market Outlook to 2018 - India and China Present Bright Prospects
- PharmaPoint: Postmenopausal Vaginal Atrophy - US Drug Forecast And Market Analysis To 2022
- Global Dermatological Drugs Market 2014-2018
- Biosimilars Market - Global Forecast to 2018
- Global Orphan Drugs Market 2014-2018
- Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat
- Global Osteoporosis Drugs Market 2014-2018
- Global Non-melanoma Skin Cancer Market 2014-2018